12 pending office actions • 11 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 7 (58%) |
| No statute on record | 5 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, DENNIS MICHAEL | 1 | 57.4% | +48.8% |
| FOLEY, SHANON A | 1 | 73.7% | +18.1% |
| BREWSTER, HAYDEN R | 1 | 61.9% | +48.4% |
| ROYCE, LIAM A | 1 | 65.0% | +21.8% |
| POPA, ILEANA | 1 | 21.0% | +14.9% |
| PATTERSON, SARAH COOPER | 1 | 58.6% | +56.4% |
| ALLEN, SARAH ELIZABETH | 1 | 61.9% | +44.4% |
| TRAN, CHRISTINA L | 1 | 46.8% | +51.2% |
| MEJIAS, SAMANTHA LEE | 1 | 47.4% | +62.5% |
| JUEDES, AMY E | 1 | 44.5% | +41.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18172176 | PRODUCTION OF EXTRACELLULAR VESICLES IN SINGLE-CELL SUSPENSION USING CHEMICALLY-DEFINED CELL CULTURE MEDIA | POPA, ILEANA | 9d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18246301 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | BREWSTER, HAYDEN R | 44d overdue |
| 17634897 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | MEJIAS, SAMANTHA LEE | 3d overdue |
| 17594401 | METHODS OF TREATING TUBERCULOSIS | JUEDES, AMY E | 1d overdue |
| 18246312 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | ROYCE, LIAM A | 7d |
| 17635322 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 | TRAN, CHRISTINA L | 7d |
| 18172176 | PRODUCTION OF EXTRACELLULAR VESICLES IN SINGLE-CELL SUSPENSION USING CHEMICALLY-DEFINED CELL CULTURE MEDIA | POPA, ILEANA | 9d |
| 17793629 | CHOLESTEROL ASSAYS FOR QUANTIFYING EXTRACELLULAR VESICLES | WHITE, DENNIS MICHAEL | 20d |
| 17763973 | STING AGONIST COMPRISING EXOSOMES COMBINED WITH IL-12 DISPLAYING EXOSOMES FOR TREATING A TUMOUR | PATTERSON, SARAH COOPER | 34d |
| Art Unit | Apps |
|---|---|
| 1637 | 2 |
| 1758 | 1 |
| 1671 | 1 |
| 1779 | 1 |
| 1777 | 1 |
| 1633 | 1 |
| 1675 | 1 |
| 1618 | 1 |
| 1644 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17793629 | CHOLESTEROL ASSAYS FOR QUANTIFYING EXTRACELLULAR VESICLES | WHITE, DENNIS MICHAEL | 1758 | §103 | Non-Final OA | 20d | Pending | Sep 05, 2023 |
| 18246304 | METHODS OF PRODUCING EXTRACELLULAR VESICLES | FOLEY, SHANON A | 1671 | Other | Non-Final OA | 42d | Pending | Mar 22, 2023 |
| 18246301 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | BREWSTER, HAYDEN R | 1779 | §103 | Non-Final OA | 44d overdue | Pending | Mar 22, 2023 |
| 18246312 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | ROYCE, LIAM A | 1777 | §103 | Non-Final OA | 7d | Pending | Mar 22, 2023 |
| 18172176 | PRODUCTION OF EXTRACELLULAR VESICLES IN SINGLE-CELL SUSPENSION USING CHEMICALLY-DEFINED CELL CULTURE MEDIA | POPA, ILEANA | 1633 | §103 | Final Rejection | 9d | Pending | Feb 21, 2023 |
| 17763973 | STING AGONIST COMPRISING EXOSOMES COMBINED WITH IL-12 DISPLAYING EXOSOMES FOR TREATING A TUMOUR | PATTERSON, SARAH COOPER | 1675 | Other | Final Rejection | 34d | Pending | Mar 25, 2022 |
| 17635298 | EXTRACELLULAR VESICLES WITH ANTISENSE OLIGONUCLEOTIDES TARGETING KRAS | ALLEN, SARAH ELIZABETH | 1637 | §103 | Non-Final OA | 47d | Pending | Feb 14, 2022 |
| 17635322 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 | TRAN, CHRISTINA L | 1637 | §103 | Non-Final OA | 7d | Pending | Feb 14, 2022 |
| 17634897 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | MEJIAS, SAMANTHA LEE | 1618 | §103 | Non-Final OA | 3d overdue | Pending | Feb 11, 2022 |
| 17594401 | METHODS OF TREATING TUBERCULOSIS | JUEDES, AMY E | 1644 | Other | Non-Final OA | 1d overdue | Pending | Oct 14, 2021 |
| 17441162 | EXTRACELLULAR VESICLE CONJUGATES AND USES THEREOF | ANTHOPOLOS, PETER | 1611 | Other | Non-Final OA | 17d overdue | Pending | Sep 20, 2021 |
| 17293833 | ENGINEERED EXTRACELLULAR VESICLES AND USES THEREOF | ESPINOSA, CLAUDIA EDILMA | 1654 | Other | Non-Final OA | 13d | Pending | May 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial